Japan Physician Survey: Nearly Half Reluctant To Use GLP-1 Receptor Agonists
This article was originally published in PharmAsia News
Nearly one-third of Japanese doctors actively prescribe GLP-1 receptor agonists for the treatment of type 2 diabetes, while 48.4% do not, according to a MedPeer survey targeting metabolism and endocrinology physicians in Japan.
You may also be interested in...
The Trump administration does not believe its partnership with industry on therapeutics for COVID-19 should include conditions on pricing, US Health Secretary Alex Azar tells Congress.